MacLennan W J, Hamilton J C
Br Med J. 1977 Oct 1;2(6091):859-61. doi: 10.1136/bmj.2.6091.859.
Serial 25-hydroxy vitamin D (25-OHD) concentrations were measured in long-stay geriatric patients treated with vitamin D. Comparison between a treatment and a control group showed that a daily dose of 500 IU vitamin D produced a significant increase in 25-OHD levels by two months. The supplement had a striking effect when the initial 25-OHD level was low and very little effect when it was high. 25-OHD levels in subjects on 2000 IU vitamin D daily were only marginally higher than those in subjects on 500 IU. A dose of 500 IU vitamin D daily should therefore produce adequate blood 25-OHD concentrations in most old people, and probably prevent most cases of osteomalacia in the elderly--though a large-scale study is needed to confirm this.
对接受维生素D治疗的长期住院老年患者进行了连续的25-羟基维生素D(25-OHD)浓度测量。治疗组与对照组的比较表明,每日500国际单位的维生素D剂量在两个月时使25-OHD水平显著升高。当初始25-OHD水平较低时,补充剂有显著效果,而当水平较高时效果甚微。每日服用2000国际单位维生素D的受试者的25-OHD水平仅略高于服用500国际单位的受试者。因此,每日500国际单位的维生素D剂量应该能在大多数老年人中产生足够的血液25-OHD浓度,并可能预防大多数老年人的骨软化症——尽管需要大规模研究来证实这一点。